D3A – Benign neuroendocrine tumors
ICD-10-CM 2027 diagnosis code · Benign neuroendocrine tumors (D3A)
ICD-10-CM code
D3A
- Code
D3A(claims format:D3A)- Description
- Benign neuroendocrine tumors
- Billable
- No – use a more specific code below
- Valid for
- Dates of service October 1, 2026 – September 30, 2027 (FY2027)
- Chapter
- 2. Neoplasms (C00-D49)
- Block
- D3A Benign neuroendocrine tumors (D3A)
Billable codes under D3A
D3A is a header code and cannot be used on claims. Choose the most specific code:
- D3A.0 – Benign carcinoid tumorsHeader (more codes below)
- D3A.8 – Other benign neuroendocrine tumorsBillable
Notes for D3A
Excludes2 (not included here):
- benign pancreatic islet cell tumors (D13.7)
Use additional code:
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.00)
Code also:
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Frequently asked questions
What is ICD-10 code D3A?
D3A is the ICD-10-CM code for benign neuroendocrine tumors, in the block D3A (Benign neuroendocrine tumors (D3A)).
Is D3A a billable code?
No. D3A is a header code with more specific child codes; report one of the billable codes listed above.
Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.